How Recursion Is Using AI to Rethink Drug Discovery
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.
Add to cart failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
How Recursion Is Using AI to Rethink Drug Discovery
-
Narrated by:
-
Written by:
In this episode, Ed is joined by Ben Taylor, Chief Financial Officer and President of Recursion UK, to discuss how AI is reshaping drug discovery, biotech, and the future of medicine.
Ben explains how Recursion uses AI, lab automation, biological data, and machine learning to improve the way new medicines are discovered and developed. They explore why drug discovery has such a high failure rate, how AI can open up new areas of biology, and what this could mean for healthcare over the next decade.
adbl_web_anon_alc_button_suppression_t1
No reviews yet